Hysteroscopic lysis of intrauterine adhesions (IUAs) is the primary initial treatment in patients with Asherman’s syndrome who have symptoms. These six steps can help improve outcomes with the procedure.
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More